Operational Group Structure
Lonza’s activities are organized into the following segments:
The Pharma&Biotech segment covers Custom Development and Manufacturing offerings directed to pharmaceutical markets, as well as offerings from Lonza’s Bioscience Solutions business for the bioresearch market. In the reporting year, it included five business units: Mammalian Manufacturing, Chemical and Microbial Manufacturing, Clinical Development and Manufacturing, Emerging Technologies and Bioscience Solutions.2 This all-encompassing segment offers pharmaceutical and biotech industries Lonza’s recognized development and manufacturing know-how and broad technology platform.
The Specialty Ingredients segment includes consumer-oriented offerings with four business units in the reporting year: Consumer Health, Agro Ingredients, Coatings and Composites, and Water Care.3
Operational Units are divided into four: Pharma&Biotech Operations and Research & Development, along with Specialty Ingredients Operations and Research & Technology. After closing of the Capsugel acquisition on 5 July 2017, Capsugel remained an independent operational unit within the Lonza structure to prepare functional and business integration. From 1 January 2018, Capsugel has been fully integrated within the Lonza Operational Units mentioned above.
The Corporate Functions include Human Resources, Finance & Controlling, IT, Corporate Development, Engineering, Legal / Ethics & Compliance/ IP, Procurement, Quality, Corporate Communications and Investor Relations and Environment, Health and Safety.
Global Business Service Organization
The Global Business Service Organization (GBSO) supports our market activities by implementing corporate guidelines and driving service excellence. The GBSO is helping to facilitate Lonza’s profitable growth by establishing standardized and harmonized solutions that enable the implementation of innovations at pace and scale. Key focus areas are on the critical business support functions.
Holding Company and Listed Companies
Lonza Group Ltd, with registered office in Basel (CH), is the ultimate parent company of the Lonza Group. Except for Lonza Group Ltd, no company belonging to the Lonza Group is listed. Please refer to the Shares and Participation Certificates section, for information on the listed shares, the stock exchanges on which Lonza Group Ltd is listed and the market capitalization.
Principal Subsidiaries and Joint Ventures
The principal subsidiaries and joint ventures of the Lonza Group are shown in Note 33: Principal Subsidiaries and Joint Ventures.
According to disclosure notifications filed with Lonza, the following shareholders held more than 3% of the Lonza share capital as of 31 December 2017.
|BlackRock, Inc., New York, NY (USA)||9.67|
|Massachusetts Mutual Life Insurance Company, Springfield, MA (USA)||4.06|
Lonza Group Ltd has not entered into any cross-shareholdings.